EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Filter the list

Prikazano 651 - 700 od 4.821 rezultata.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
Yatapox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yellow fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Yersinia enterocolitica	-	-		B Bacteria and similar species
Yersinia pestis	-	-		B Bacteria and similar species
Yersinia pseudotuberculosis	-	-		B Bacteria and similar species
Yersinia spp.	-	-		B Bacteria and similar species
zinc chromates including zinc potassium chromate show/hide Zinc dichromate EC / List no: 237-843-0 \| CAS no: 14018-95-2 Pentazinc chromate octahydroxide EC / List no: 256-418-0 \| CAS no: 49663-84-5 C.I. Pigment Yellow 36 EC / List no: 609-398-6 \| CAS no: 37300-23-5 Potassium hydroxyoctaoxodizincatedichromate(1-) EC / List no: 234-329-8 \| CAS no: 11103-86-9 Zinc chromate EC / List no: 236-878-9 \| CAS no: 13530-65-9	-	-	Carc. 1A; Acute Tox. 4; Skin Sens. 1
zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex	425-240-7	-	Eye Dam. 1
Zirconia Aluminosilicate Refractory Ceramic Fibres	936-037-2	-			yes
'amyl nitrite', mixed isomers	203-770-8	110-46-3	Flam. Liq. 2; Acute Tox. 4
(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)	430-460-1	133636-82-5	Skin Corr. 1B; Skin Sens. 1
(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride	432-360-3	105813-13-6	Acute Tox. 4; Skin Sens. 1
(-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine BRL 29226	406-030-4	105812-81-5	Acute Tox. 4; Eye Dam. 1
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate	214-619-0	1166-46-7	Carc. 2; Acute Tox. 4; STOT SE 2
(1-hydroxydodecylidene)diphosphonic acid KELCOR; LIPOKEL; SEQUOL	425-230-2	16610-63-2	Skin Corr. 1B
(1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptanes dihydrobromide CP-84,203-4; DFX-5S	411-000-9	125224-62-6	Skin Sens. 1
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene	-	135821-03-3			yes
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene	-	135821-74-8			yes
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride	426-200-1	172015-79-1	STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
(2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(-3-(diethylammonio)propylamino)1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate BLUE 10 25 964	407-240-9	159604-94-1	Skin Sens. 1
(2,3-dimethylbut-2-yl)-trimethoxysilane	439-360-2	142877-45-0	Skin Irrit. 2; Eye Dam. 1
(2,6-xylyloxy) acetic acid	430-910-7	13335-71-2	Acute Tox. 4; Eye Dam. 1
(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone BUTAMINONITRODARONE; SR33581	444-800-1	141645-23-0	Flam. Liq. 3; Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(2R, 3S, 4R, 5R, 7R, 9R, 10R,11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane	433-820-6	118058-74-5	Eye Irrit. 2
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole	822-682-6	1417782-03-6	Skin Sens. 1
(3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid CIN 10094329; SENSIBILISATOR KF 693 PINA; SENSITIZER KF 693 PINA	422-240-9	166596-68-5	Eye Dam. 1; Skin Sens. 1
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one	701-394-3	1782069-81-1			yes
(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide	420-380-5	136465-81-1	Acute Tox. 4; Eye Dam. 1
(3S, 6R, 9S, 12R, 15S, 18R, 21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone	444-350-6	133413-70-4	Eye Irrit. 2
(3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide PTH-AA	430-230-0	136522-17-3	Acute Tox. 4
(4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate(1-) PHOTOAMORCEUR 22074; RHODORSIL PHOTOINITIATOR 2074; TEPBI	422-960-3	178233-72-2	Acute Tox. 4; STOT RE 2
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane SILANEOPHAN	405-020-7	105024-66-6	Repr. 1B
(4aR,8aR)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one	428-690-2	1668-86-6	Acute Tox. 4; Eye Irrit. 2
(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine	425-930-8	151213-39-7	Skin Corr. 1B; Acute Tox. 4; STOT RE 2
(6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 2691; CARTASOL BRILLANT SCHARLACH K-2GL KONZ.; CARTASOL BRILLANTSCHARLACH K-2GL FLÜSSIG (ZUBEREITUNG); CARTASOL BRILLANTSCHARLACH K-2GL GRANULAT (ZUBEREITUNG); CARTASOL BRILLIANT SCARLET K-2GL; CARTASOL BRILLIANT SCARLET K-2GL CONC.	402-060-7	108225-03-2	Carc. 1B; Eye Dam. 1
(6R-trans)-1-((7-ammonio-2- carboxylato-8-oxo-5-thia-1- azabicyclo-[4.2.0]oct-2-en-3- yl)methyl)pyridinium iodide	423-260-0	100988-63-4	Muta. 2; Skin Sens. 1
(E)-2-butenal; (E)-crotonaldehyde	204-647-1	123-73-9	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
(E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal DPP	410-980-5	112704-51-5	Eye Irrit. 2; Skin Sens. 1
(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal PYRIDYLACROLEIN	426-330-9	177964-68-0	Eye Irrit. 2; Skin Sens. 1
(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol	423-240-1	125474-34-2	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
(ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised AOC 1020X	402-370-2	149057-70-5	Flam. Liq. 3; Eye Dam. 1
(methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'dipyridinium dichloride dihydrochloride CARTASOL GEEL M-GL CONC.; CARTASOL GELB M-GL FLÜSSIG (ZUBEREITUNG); CARTASOL GELB M-GL KONZ.; CARTASOL YELLOW M-GL CONC.; HM 2580	401-500-5	118658-99-4	Carc. 1B
(N-benzyl-N, N,N-tributyl)ammonium 4-dodecylbenzenesulfonate TICA 118	422-200-0	178277-55-9	Skin Corr. 1B; Acute Tox. 4
(R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %)	-	178961-20-1	Skin Sens. 1
(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole	430-560-5	180637-89-2	Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Skin Sens. 1
(R)-butan-2-ol	238-967-8	14898-79-4	Flam. Liq. 3; Eye Irrit. 2; STOT SE 3
(R)-sec-butylamine; (R)-2-aminobutane	236-232-6	13250-12-9	Flam. Liq. 2; Acute Tox. 4; Skin Corr. 1A
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile	430-780-1	103146-25-4	Acute Tox. 4; Skin Sens. 1

Prikazano 651 - 700 od 4.821 rezultata.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Contact Helpdesk

Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.

Footer Nav Items